spry2 sprouty RTK signaling antagonist 2
Phenotypes manually curated with terms from the Xenopus phenotype ontology covering anatomical, gene ontology, and neurobehavioral phenotypes.
|abnormal cell migration (5 sources), abnormal retina (5 sources), abnormally decreased number of retinal progenitor cell (3 sources), increased MAP kinase activity (2 sources), abnormal cell division (1 source), abnormal protein phosphorylation (1 source), decreased MAP kinase activity (1 source), decreased size of the eye (1 source), increased size of the proliferative region (1 source)|
Gene expression phenotype annotations where the gene of interest has been disrupted (manipulated) or is the gene assayed (assayed). Computed annotations are derived from differential expression analysis from Xenbase processed GEO data with the criteria of a TPM >= 1, FDR <= 0.05 and an absolute LogFC >= 2.
|Manual annotations: spry2 manipulated (1 source), spry2 assayed (3 sources)|
|Computed annotations: spry2 assayed (15 sources)|
Diseases from the human disease ontology (DO) manually associated with phenotypes from disease models. Sources are grouped by anatomical (AP) and expression (EP) phenotypes.
|microphthalmia (1AP source)|
These are short form descriptions of experiments using reagents targeting the gene of interest.
|Xla Wt + spry2 MO (7 sources), Xla Wt + spry2 (2 sources), Xla Wt + spry2 MO (1 source), Xla Wt + spry2dn (1 source)|